Autosomal Recessively Inherited Glucose Transporter-1 Deficiency Syndrome with Acanthocytosis: A Case Report

被引:0
|
作者
Wanigasinghe, Jithangi [1 ,3 ]
Jayasundara, Kasun [2 ]
Jasinghe, Eresha [2 ]
机构
[1] Univ Colombo, Dept Paediat, Colombo, Sri Lanka
[2] Lady Ridgeway Hosp Children, Colombo, Sri Lanka
[3] Univ Colombo, Fac Med, Dept Paediat, 25 Kynsey Rd, Colombo 8, Sri Lanka
关键词
classical; glucose transporter-1 deficiency syndrome; red cell morphology; GLUT1; DEFICIENCY; MUTATIONS; SLC2A1;
D O I
10.1055/s-0043-57007
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Glucose transporter-1 deficiency syndrome (GLUT-1DS) is a rare, autosomal dominantly inherited disorder due to a heterozygous mutation in the gene solute channel 2A1 ( SLC2A1 ).This gene encodes the glucose transporter protein-1. Autosomal recessive inheritance is extremely rare. Similarly, only very few reports are found in the literature of hematological manifestations in this syndrome. We report an autosomal recessively inherited GLUT-1DS, due to a de novo mutation, with the classical infantile presentation associated with concomitant acanthocytosis. In this case report, the second child born to consanguineous parents with initial refractory neonatal seizures and subsequent poorly controlled epilepsy and developmental regression is discussed. The most notable investigation findings supportive of his underlying diagnosis were very low cerebrospinal fluid (CSF) glucose and CSF lactate levels. His CSF:plasma glucose ratio was 1:7.6. He was anemic with a hemoglobin of 8.8 g/dL with his blood film showing marked acanthocytosis. His elder brother who also had refractory epilepsy and developmental regression had similar hypoglycorrhachia, low CSF:plasma glucose ratio, and mild anemia with acanthocytosis, and he died before establishment of a diagnosis. Our patient was diagnosed to have a novel mutation SLC2A1 c.184A > G p.(Thr62Ala), for which both parents were heterozygous, confirming autosomal recessive inheritance. Commencement of a ketogenic diet resulted in improvement of his seizures and slow gain in development. It also resulted in gradual disappearance of acanthocytes from his peripheral blood. This case describes a rare case of classical GLUT-1DS, autosomal recessively inherited, due to a novel mutation. The acanthocytosis in his blood smear is another rare association minimally reported in GLUT-1DS. The cause of his abnormal red blood cell morphology is unclear. It is possibly related to cation leakage reported in some rare mutations of the SLC2A1 gene needs reference.
引用
收藏
页码:453 / 457
页数:5
相关论文
共 50 条
  • [41] First-in-Class Dual Targeting Compounds for the Management of Seizures in Glucose Transporter Type 1 Deficiency Syndrome
    Angeli, Andrea
    Ferraroni, Marta
    Granchi, Carlotta
    Minutolo, Filippo
    Chen, Xiaozhuo
    Shriwas, Pratik
    Russo, Emilio
    Leo, Antonio
    Selleri, Silvia
    Carta, Fabrizio
    Supuran, Claudiu T.
    JOURNAL OF MEDICINAL CHEMISTRY, 2023, 66 (14) : 10010 - 10026
  • [42] Favourable response to ketogenic dietary therapies: undiagnosed glucose 1 transporter deficiency syndrome is only one factor
    Schoeler, Natasha E.
    Cross, Judith Helen
    Drury, Suzanne
    Lench, Nicholas
    McMahon, Jacinta M.
    MacKay, Mark T.
    Scheffer, Ingrid E.
    Sander, Josemir W.
    Sisodiya, Sanjay M.
    DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2015, 57 (10): : 969 - 976
  • [43] Prognostic significance of glucose transporter-1 (GLUT1) gene expression in rectal cancer after preoperative chemoradiotherapy
    Saigusa, Susumu
    Toiyama, Yuji
    Tanaka, Koji
    Okugawa, Yoshinaga
    Fujikawa, Hiroyuki
    Matsushita, Kohei
    Uchida, Keiichi
    Inoue, Yasuhiro
    Kusunoki, Masato
    SURGERY TODAY, 2012, 42 (05) : 460 - 469
  • [44] Glucose Transporter 1 Deficiency: A Treatable Cause of Opsoclonus and Epileptic Myoclonus
    Appavu, Brian
    Mangum, Tara
    Obeid, Makram
    PEDIATRIC NEUROLOGY, 2015, 53 (04) : 364 - 366
  • [45] Glucose Transporter 1 Deficiency as a Treatable Cause of Myoclonic Astatic Epilepsy
    Mullen, Saul A.
    Marini, Carla
    Suls, Arvid
    Mei, Davide
    Della Giustina, Elvio
    Buti, Daniela
    Arsov, Tudor
    Damiano, John
    Lawrence, Kate
    De Jonghe, Peter
    Berkovic, Samuel F.
    Scheffer, Ingrid E.
    Guerrini, Renzo
    ARCHIVES OF NEUROLOGY, 2011, 68 (09) : 1152 - 1155
  • [46] Hemidystonia and hemichorea in a pediatric patient with glucose transporter type 1 deficiency
    Menalleda, Graciela S.
    Montero, Susana
    Faustinelli, Valeria
    Poeta Casalis, Laura del, V
    Crespo, Dolores
    Colombo, Hector
    ARCHIVOS ARGENTINOS DE PEDIATRIA, 2022, : E207 - E209
  • [47] A Patient with Glucose Transporter Type 1 Deficiency Syndrome: Paroxysmal Choreoathetosis and Cerebral Positron-Emission Tomography Findings
    Yapici, Zuhal
    Topaloglu, Pinar
    Turkmen, Cuneyt
    Eraksoy, Mefkure
    Zuberi, Sameer
    NEUROLOGICAL SCIENCES AND NEUROPHYSIOLOGY, 2022, 39 (01): : 53 - 55
  • [48] Diagnostic and Clinical Manifestation Differences of Glucose Transporter Type 1 Deficiency Syndrome in a Family with SLC2A1 Gene Mutation
    Pawlik, Weronika
    Okulewicz, Patrycja
    Pawlik, Jakub
    Krzywinska-Zdeb, Elzbieta
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (06)
  • [49] ASHERMAN SYNDROME WITH FACTOR 7 DEFICIENCY: CASE REPORT
    Malkan, U. Y.
    Gunes, G.
    Eliacik, E.
    Isik, A.
    Sayinalp, N.
    Ozcebe, O. I.
    Aksu, S.
    LEUKEMIA RESEARCH, 2014, 38 : S34 - S34
  • [50] An in vitro model of glucose transporter 1 deficiency syndrome at the blood-brain barrier using induced pluripotent stem cells
    Iqra, Pervaiz
    Tuz, Zahra Fatema
    Constantinos, Mikelis
    Jacob, Al-Ahmad Abraham
    JOURNAL OF NEUROCHEMISTRY, 2022, 162 (06) : 483 - 500